Coherus BioSciences Inc (CHRS) — Capital Reinvestment Ratio
Latest as of September 2021:
0.02x
Coherus BioSciences Inc (CHRS) has a Capital Reinvestment Ratio of 0.02x as of September 2021, meaning it reinvests 0% of its operating cash flow ($13.71 Million) in capital expenditures ($261.00K). See CHRS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$13.71 Million
USD
Capital Expenditures
$261.00K
USD
Data as of
Sep 2021
Most recent filing
Coherus BioSciences Inc Capital Reinvestment Ratio (2013–2020)
This chart tracks Coherus BioSciences Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Coherus BioSciences Inc (2013–2020)
Year-by-year Capital Reinvestment Ratio for Coherus BioSciences Inc from 2013 to 2020. For live market cap and broader valuation context, see CHRS company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $154.15 Million | $7.23 Million | ▼ -89.7% |
| 2019 | 0.45x | $28.36 Million | $12.90 Million | ▲ +1780.7% |
| 2013 | 0.02x | $15.42 Million | $373.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow